title: [Lanthanide fluorescence immunoassay of 17alpha-hydroxyprogesterone in dried blood samples for neonatal screening for adrenogenital syndrome].
abstract: The first Russian assay of 17alpha-hydroxyprogesterone in dried blood spots has been developed to use for neonatal screening for adrenogenital syndrome (AGS). The technique is modeled on solid-phase lanthanide fluorescence immunoassay with time-resolution detection and it ensures the hormone to be determined in a 3.2-mm dried blood spot in the concentration range of 0 to 400 nmol/l, the coefficient of variation being not greater than 15%, and the results correlated with those of the DELFIA Neo170HP test system. The tests of 387 dried blood samples carried out in three regions have demonstrated the efficiency of the technique for screening and verifying neonatal AGS.
authors.forename: N I
authors.initials: NI
authors.lastname: Bekman
authors.forename: S Iu
authors.initials: SIu
authors.lastname: Laricheva
authors.forename: V G
authors.initials: VG
authors.lastname: Pomelova
authors.forename: N S
authors.initials: NS
authors.lastname: Osin
mesh_terms: D019326:17-alpha-Hydroxyprogesterone / Q000097:blood* / Q000737:chemistry; D047808:Adrenogenital Syndrome / Q000097:blood* / Q000175:diagnosis; D005063:Europium / Q000737:chemistry*; D005260:Female; D005453:Fluorescence; D006801:Humans; D007163:Immunosorbent Techniques / Q000295:instrumentation; D007231:Infant, Newborn; D049408:Luminescent Agents / Q000737:chemistry*; D008297:Male; D008403:Mass Screening / Q000295:instrumentation / Q000379:methods; D012680:Sensitivity and Specificity
chemical_list: D049408:Luminescent Agents; D005063:Europium; D019326:17-alpha-Hydroxyprogesterone